Clinical Trials Sponsored by Kasey Phifer

Total 5851 results

Pfizer

Completed

Bioavailability Study of Naloxone 5 Milligrams (mg) Intramuscular (IM) Autoinjector

Healthy Volunteers

United States
Pfizer

Completed

A Study to Describe the Safety and Immunogenicity of a RSV Vaccine in Healthy Adults

Respiratory Tract Infections

United States
Pfizer

Completed

"Retrospective Study to Identify Clinical Factors Related to a High Benefit of Axitinib in mRCC"

Carcinoma, Renal Cell

Spain
Pfizer

Withdrawn

Study to Investigate the Mass Balance, Metabolism, and Excretion of [14C]PF-07321332 in Healthy Male Participants.

Healthy Participants
Pfizer

Terminated

A Study of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or Metastatic RAS-mutant Solid Tumors

Pancreatic Cancer

Belgium, United States, Singapore
Pfizer

Completed

Bioequivalence Study for Crizotinib Encapsulated Microsphere Formulation (eMS)

Healthy Participants

United States
Pfizer

Completed

Palbociclib Plus Letrozole For Postmenopausal Women With HR(+) HER2(-) Advanced Breast Cancer For Whom Letrozole Is Deemed Appropriate

Advanced Breast Cancer Female

Mexico, Argentina, Brazil, Colombia
Pfizer

Completed

Patient Characteristics, Treatment Patterns And Incidence Of Events (Discontinuation, Persistence, Key Primary Clinical Outcomes) In NVAF Patients Initiating OAC Therapy In Colombia

Atrial Fibrillation

Colombia
Pfizer

Terminated

A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD

Atopic Dermatitis

United States, Poland, Germany, United Kingdom, Italy, Sweden, Switzerland
Pfizer

Terminated

Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.

Ulcerative Colitis

United States, Australia, Italy, Korea, Republic of, Belgium, Israel, Turkey, Saudi Arabia, Germany, Serbia
Pfizer

Completed

REGISTRY OF COMPLETE RESPONSES TO SUNITINIB IN SPANISH PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (ATILA)

Carcinoma, Renal Cell

Spain
Pfizer

Completed

Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-naïve Adults

Pneumococcal Disease

United States, Sweden
Pfizer

Withdrawn

A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery

Pulmonary Embolism | Cerebral Stroke | Thrombosis, Deep Vein
Pfizer

Completed

Study in Healthy Adults Evaluating PF-07202954

Liver Fibrosis | Non-Alcoholic Fatty Liver Disease

United States
Pfizer

Completed

A Study Evaluating Relative Bioavailability of an Oral Suspension of Abrocitinib and Effect of an Acid Reducing Agent on the Bioavailability of Abrocitinib and Assessing the Taste of Abrocitinib Oral Formulations.

Healthy Volunteers

United States
Pfizer

Completed

Efficacy and Safety of IV Diclofenac (DIV075V)for Pain After Elective Orthopedic Surgery

Postoperative Pain

United States
Pfizer

Completed

Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China

Breast Neoplasms

China
Pfizer

Completed

Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).

Plaque Psoriasis

Iraq
Pfizer

Completed

An Open-Label Safety Study Of DIC075V (Intravenous Diclofenac Sodium) In Patients With Acute Post-Operative Pain

Pain, Postoperative

United States
Pfizer

Completed

Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel

Spondyloarthrosis

Iraq
Pfizer

Terminated

A BRIDGING STUDY OF PF-06439535 (CN) PLUS PACLITAXEL-CARBOPLATIN VERSUS BEVACIZUMAB PLUS PACLITAXEL-CARBOPLATIN IN NSCLC

Advanced Non-squamous NSCLC

China
Pfizer

Terminated

Actual Use and Compliance Study Of Ibuprofen 600 Mg Immediate Release/Extended Release Tablets In At-Risk OTC Consumers

Pain

United States
Pfizer

Completed

Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty

Scar Prevention

United States
Pfizer

Completed

Study To Evaluate The Impact Of Anti-Cyclic Citrullinated Peptide(Anti-CCP) For Management With Enbrel In Patients With Psoriatic Arthritis(PsA)

Psoriatic Arthritis

Iraq
Pfizer

Completed

Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery

Reduction in Hypertrophic Skin Scarring

United States
Pfizer

Completed

A Safety Study For Prevenar 13 Among Chinese Children

Apnea | Fever | Seizures | Urticaria and Angioedema

China
Pfizer

Terminated

Amlodipine And Olmesartan Medoxomil In Hypertensive Filipino Patients

Hypertension

Philippines
Pfizer

Completed

Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis

Arthritis, Rheumatoid

Hong Kong, United States, Spain, Israel, Finland, Thailand, Turkey, Taiwan, Poland, Czechia, Malaysia, South Africa, Mexico, China, Australia, Slovakia, United Kingdom, New Zealand, Jordan, Canada, Netherlands, Brazil, Colombia, Puerto... and more
Pfizer

Completed

A Study To Compare Pregabalin/PF-00489791 Combination Versus Pregabalin Alone In Post-Herpetic Neuralgia

Postherpetic Neuralgia

United States
Pfizer

Completed

Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty

Scar Prevention

United States
Pfizer

Completed

Diflucan Research For Infant Evaluation Of Antifungal Treatment And Prophylaxis Medication (DREAM)

Deep Mycosis
Pfizer

Completed

A Study Of Diflucan In Children With Ringworm Of The Scalp

Tinea Capitis

United States, Puerto Rico
Pfizer

Completed

RN624 In Adult Patients With Chronic Low Back Pain

Low Back Pain

United States
Pfizer

Completed

Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in BRAF Mutant Metastatic Colorectal Cancer

Colorectal Cancer

United States, Canada, Australia, Germany, Japan, Netherlands, Spain, France, Belgium, Korea, Republic of, Italy, Norway
Pfizer

Terminated

A Renal Impairment Study for PF-06651600

Renal Impairment

United States
Pfizer

Terminated

Tanezumab In Osteoarthritis Of The Hip Or Knee

Osteoarthritis

United States, Spain, Germany, Poland, Denmark, Austria, Sweden
Pfizer

Completed

Tanezumab In Osteoarthritis Of The Knee (2)

Arthritis | Osteoarthritis

United States
Pfizer

Terminated

A Long Term Study of the Safety of Tanezumab When Administered By Subcutaneous Injections

Osteoarthritis, Knee | Osteoarthritis, Hip

United States
Pfizer

Terminated

Extension Study Of Tanezumab In Osteoarthritis

Osteoarthritis

United States
Pfizer

Completed

BIOEQUIVALENCE STUDY IN HEALTHY PARTICIPANTS COMPARING 4 MG AND 8 MG FESOTERODINE EXTENDED-RELEASE TABLETS (TOVIAZ™), MANUFACTURED AT ZWICKAU VERSUS FREIBURG

Neurogenic Detrusor Overactivity

Belgium
Pfizer

Terminated

Efficacy And Safety Study Of Tanezumab Subcutaneous Administration In Osteoarthritis - A Subcutaneous/Intravenous Bridging Study

Pain | Arthritis | Osteoarthritis

United States
Pfizer

Completed

Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Hemophilia A Patients

Hemophilia A

India
Pfizer

Completed

Efficacy and Safety of a Subcutaneous Tanezumab Titration Dosing Regimen in Subjects With Moderate to Severe Osteoarthritis of the Hip or Knee

Osteoarthritis, Knee | Osteoarthritis, Hip

United States, Puerto Rico, Canada
Pfizer

Terminated

Long Term Safety Study of Tanezumab in Chronic Low Back Pain

Low Back Pain

United States
Pfizer

Completed

Vfend Special Investigation For Pediatric - Observational

Pediatric Safety and Effectiveness

Japan
Pfizer

Completed

Effect Of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of PF-06865571 In Subjects With Hepatic Impairment and in Healthy Subjects

Healthy Volunteers | Hepatic Impairment

United States
Pfizer

Terminated

Safety And Efficacy Of Tanezumab In Patients With Chronic Pancreatitis

Chronic Pancreatitis

United States
Pfizer

Completed

Tanezumab in Osteoarthritis of the Knee

Arthritis | Osteoarthritis

United States
Pfizer

Completed

Estimation of the Effect of Multiple Dose Ritlecitinib (PF-06651600) on the Pharmacokinetics of a Single Dose of Caffeine in Healthy Participants

Healthy Participants

United States
Pfizer

Completed

A Study to Determine the Bioequivalence of Two Doses of Tafamidis

Healthy

United States

3

Subscribe